Applied DNA Sciences

Innovation in the Age of Coronavirus

The COVID-19 pandemic and its evolving aftermath are reshaping the world around us, and myriad Long Island forces – large and small, corporate and nonprofit, industrial and academic – have risen to the challenge. Innovate Long Island presents Innovation in the Age of Coronavirus as a real-time journal of this region’s resourceful response to the greatest global challenge since World War II. Stay healthy, dear readers.     ‘Like waiting in line at the DMV’…


NYCB rises above pandemic with ‘impressive’ 2Q

  NEW YORK COMMUNITY BANCORP INC. Headquarters: Westbury Industry: Finance NYSE: NYCB Reporting Date: July 29, 2020 Reporting Quarter: 2Q FY2020 Quarter Ended: June 30, 2020  Numbers: Net income for the second quarter was reported as $105.3 million, an 8.3 percent rise above the $97.2 million reported for the same quarter last fiscal year. Total quarterly revenues (up 10.1 percent, to $281.2 million) and net income available to shareholders (up 9 percent, to $97.1 million)…


No. 518: In which pipers pipe, pilots soar and Lazarus rises – and an LI biotech cures COVID (maybe)

  Onward and upward: Welcome to Wednesday, dear readers, as the national pandemic, the coast-to-coast heat wave and our universal drive toward socioeconomic greatness all press on, undaunted. DeFina point: It’s July 22 out there, and before we dive in, a nod to reader Michael DeFina, who wrote to let us know our recent rundown of new outdoor gaming investments at Jones Beach confused the history of the state park’s Boardwalk Café with that of…


Science, numbers back Applied DNA’s COVID-19 serums

By GREGORY ZELLER // With scientists around the world racing toward a COVID-19 vaccine, serums manufactured by a Long Island biotech are showing significant promise – both medically and economically. Stony Brook-based Applied DNA Sciences and its lab partner, Italian innovator Takis Biotech, said this week that five linear-DNA based COVID-19 vaccine candidates developed by Takis and manufactured by Applied DNA “yielded strong antibody and T-cell responses” in laboratory mice, even at “very low doses”…


No. 515: In which COVID takes off, Telstar blasts off and Applied DNA spins off

  The sweeter the reward: You’ve done it again, intrepid reader, and coming off a long holiday weekend to boot – another workweek conquered, another weekend earned, Phase Four and all. Yes, it’s Friday out there, July 10 to be exact, a day so sweet you may need to floss twice: It’s National Kitten Day, National Pick Blueberries Day and National Piña Colada Day, all at once. Lose some: It’s also Independence Day in the…


Applied DNA ups ante, again, with Clinical Labs spinoff

By GREGORY ZELLER // One of Long Island’s busiest biotechs has spun off another local startup, this time focused on testing its own potential breakthroughs. Stony Brook-based Applied DNA Sciences, which has quickly evolved from an upstart DNA-based supply-chain authenticator to a leader in unique DNA manufacturing, has launched Applied DNA Clinical Labs LLC, a wholly owned subsidiary dedicated to the commercial development of two key verticals: Applied DNA’s virology tests, designed to quickly detect…


No. 509: On peanut butter cookies, LaGuardia Airport and kelp – plus baseball (remember that?)

  Phase 2 Friday: You’ve done it again, dear readers! Another tough workweek conquered – and, as your reward, Long Island’s first weekend under Phase 2 reopening protocols. Well played! It’s June 12 out there, and while you’re probably itching for your teenager to find a summer job after a half-year of home learning, it is indeed the U.N.’s World Day Against Child Labour, which is a very different matter and no joke. That’s, like,…


No. 498: On crepes, mosques and tough love – and Long Island, home of the COVID-19 vaccine?

  Schastlivaya pandemiya: Over the homebound hump we go, dear comrades, as we brave another week of the great 2020 pandemic – and, even scarier, another week locked up with those we love most. To that end, these sanity-maintenance tips from the Russian Health Ministry. You’re welcome. Crepes us out: Now here’s a dangerous combo – May 6 is both National Crepe Suzette Day, celebrating the caramelized dessert, and National No Diet Day, which, let’s…


Gains on two fronts: Same-day test, virus ‘neutralizer’

By GREGORY ZELLER // An ambitious Long Island biotech is reporting exciting progress in a two-front battle against the raging novel coronavirus. Stony Brook-based Applied DNA Sciences on Tuesday announced that it has applied for FDA approval of its Linea COVID-19 diagnostic kit, which detects SARS-CoV-2 – the novel coronavirus that causes the COVID-19 disease – with same-day results. The announcement comes one day after Applied DNA and Italian biopharma Takis Biotech said the first…


No. 493: On foundations, fellows, foreign tongues – and redemption for your pandemic pantry

  Gives us pause: It’s Friday again, dear readers, and while there’s no end in sight to the great 2020 pandemic, the same can’t be said for this latest work-from-home week of socioeconomic innovation. On blood, and bloodsuckers: It’s April 17 out there – World Hemophilia Day, when bleeding disorders take center stage, and International Bat Appreciation Day, when we give the flying rodents – which are largely insectivores and great pollinators, and almost never…


LI biotech speeds COVID-19 vaccine candidates to Italy

By GREGORY ZELLER // With preliminary lab tests looking good, an innovative Long Island biotech is rushing a quintet of potential COVID-19 vaccines overseas. Stony Brook-based Applied DNA Sciences announced Wednesday that it has completed “design qualifications” and shipped five COVID-19 vaccine candidates to Italian biopharma Takis Biotech, a frequent collaborator working closely with Applied DNA to counter the coronavirus. The vaccine candidates were produced using the Stony Brook biotech’s proprietary, polymerase chain reaction-based LinearDNA…


No. 486: On mega-moons, linear DNA and innovative immigrant services – and yes, lots of coronavirus stuff

  The unusual: Welcome to Wednesday, dear readers, and the midpoint of another weird and wild workweek, as the Great Coronavirus Pandemic continues to reshape our world and the regional and global innovation economies scramble to keep up. Please celebrate alone: It’s March 25 out there, the U.N.’s International Day of Solidarity With Missing or Detained Staff Members, which is actually about U.N. employees who made the ultimate sacrifice, but seems oddly redefined today. To…


No. 481: In which aspirin arrives, coronavirus hits home and microbes pig out

  Week strain: It’s been a stressful five days, dear readers, with the crashing stock markets and global pandemics, but you’ve persevered again – another Friday reached, another weekend on tap. Well done. It’s March 6 out there, and a fairly busy day on Planet Earth: Independence Day in Ghana, Foundation Day across the Norfolk Islands and Europe’s Day of the Righteous, honoring those who choose a moral path. Culture clash: Here in the States,…


No. 480: On coronavirus, coronavirus and coronavirus – and introducing our 2020 Master of Innovation

  Don’t worry, we washed our hands: Put ’er there, dear readers, and welcome to Wednesday, as we hurtle the hump of this latest busy (and blessedly spring-like) winter workweek. It’s March 4 out there – St. Casimir’s Day, honoring the patron saint of Poland and Lithuania, and National Pound Cake Day, celebrating the world’s most versatile cake. Strong language: It’s also National Grammar Day, a celebration of proper written and verbal grammar, desperately needed…


Island firm speeds coronavirus vaccines toward tests

By GREGORY ZELLER // Just weeks after announcing an expanded international collaboration targeting the menacing novel coronavirus, Applied DNA Sciences is preparing to mass-produce four potential vaccines. Leveraging the Stony Brook-based biotech’s unique DNA-manufacturing abilities, Rome, Italy-based Takis Biotech will test potential vaccines against the coronavirus (now going by COVID-19) in laboratory mice, on a large scale. Applied DNA expects delivery of four DNA-based “preclinical vaccine candidates” from Takis this month, and “within weeks” will…